Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Cancer. 2010 May 1;116(9):2201–2207. doi: 10.1002/cncr.25005

Table 2.

Treatment Toxicity: Grade 3+ adverse events possibly, probably, or definitely related to treatment with everolimus.

Grade
3 4 5
N % N % N %
Toxicity 5 23
Hematology Anemia
Leukopenia 3 14
Neutropenia 5 23 2 9
Thrombocytopenia 5 23 6 27
Infection/febrile neutropenia Pneumonia 2 9
Sepsis 2 9
Cellulitis 1 5
Metabolic/Laboratory Hypertriglyceridemia 2 9
Pulmonary ARDS (secondary to infection) 1 5
Constitutional symptoms Fatigue 1 5
Gastrointestinal Diarrhea 1 5